# NICE Ltd.: financial statements, quarterly

NICE · Nasdaq · CIK 1003935 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nice.md) · [Financials](/companies/nice/financials.md) · [Filings](/companies/nice/filings.md) · [Insiders](/companies/nice/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nice/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [187](/filings/0001178913-18-001044.md) | [326](/filings/0001178913-19-001056.md) | [157](/filings/0001178913-19-001056.md) | [328](/filings/0001178913-19-001056.md) | [242](/filings/0001628280-20-004618.md) | [228](/filings/0001003935-21-000006.md) | [442](/filings/0001003935-23-000005.md) | [379](/filings/0001628280-24-013301.md) | [530](/filings/0001003935-25-000004.md) | [512](/filings/0001003935-26-000010.md) | [482](/filings/0001003935-26-000010.md) | [379](/filings/0001003935-26-000010.md) |
| Current assets | $m | [485](/filings/0001178913-16-004793.md) | [655](/filings/0001178913-17-001193.md) | [509](/filings/0001178913-18-001044.md) | [693](/filings/0001178913-19-001056.md) | [861](/filings/0001628280-20-004618.md) | [876](/filings/0001003935-21-000006.md) | [1,942](/filings/0001003935-22-000008.md) | [2,298](/filings/0001003935-23-000005.md) | [2,417](/filings/0001628280-24-013301.md) | [2,313](/filings/0001003935-25-000004.md) | [2,505](/filings/0001003935-26-000010.md) | [1,379](/filings/0001003935-26-000010.md) |
| Total assets | $m | [1,633](/filings/0001178913-16-004793.md) | [1,850](/filings/0001178913-17-001193.md) | [2,632](/filings/0001178913-18-001044.md) | [2,845](/filings/0001178913-19-001056.md) | [3,207](/filings/0001628280-20-004618.md) | [3,610](/filings/0001003935-21-000006.md) | [4,233](/filings/0001003935-22-000008.md) | [4,710](/filings/0001003935-23-000005.md) | [4,854](/filings/0001628280-24-013301.md) | [5,118](/filings/0001003935-25-000004.md) | [5,296](/filings/0001003935-26-000010.md) | [5,106](/filings/0001003935-26-000010.md) |
| Current liabilities | $m | [378](/filings/0001178913-16-004793.md) | [379](/filings/0001178913-17-001193.md) | [473](/filings/0001178913-18-001044.md) | [523](/filings/0001178913-19-001056.md) | [625](/filings/0001628280-20-004618.md) | [941](/filings/0001003935-21-000006.md) | [1,044](/filings/0001003935-22-000008.md) | [1,270](/filings/0001003935-23-000005.md) | [1,141](/filings/0001628280-24-013301.md) | [1,120](/filings/0001003935-25-000004.md) | [1,474](/filings/0001003935-26-000010.md) | [888](/filings/0001003935-26-000010.md) |
| Long-term debt | $m | not reported | not reported | [444](/filings/0001178913-18-001044.md) | [448](/filings/0001178913-19-001056.md) | [456](/filings/0001628280-20-004618.md) | [213](/filings/0001003935-21-000006.md) | [421](/filings/0001003935-22-000008.md) | [429](/filings/0001003935-23-000005.md) | [455](/filings/0001628280-24-013301.md) | [457](/filings/0001003935-25-000004.md) | [0.0](/filings/0001003935-25-000004.md) | not reported |
| Current portion of debt | $m | not reported | not reported | [21.2](/filings/0001178913-18-001044.md) | not reported | [0.0](/filings/0001628280-20-004618.md) | [252](/filings/0001003935-21-000006.md) | [260](/filings/0001003935-22-000008.md) | [396](/filings/0001003935-23-000005.md) | [209](/filings/0001628280-24-013301.md) | [209](/filings/0001003935-25-000004.md) | [459](/filings/0001003935-26-000010.md) | [0.0](/filings/0001003935-26-000010.md) |
| Shareholders' equity | $m | [1,213](/filings/0001178913-18-001044.md) | [1,415](/filings/0001178913-19-001056.md) | [1,511](/filings/0001628280-20-004618.md) | [1,750](/filings/0001628280-20-004618.md) | [2,017](/filings/0001628280-20-004618.md) | [2,257](/filings/0001003935-21-000006.md) | [2,564](/filings/0001003935-22-000008.md) | [2,825](/filings/0001003935-23-000005.md) | [3,042](/filings/0001628280-24-013301.md) | [3,341](/filings/0001003935-25-000004.md) | [3,590](/filings/0001003935-26-000010.md) | [3,877](/filings/0001003935-26-000010.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 60,427,562 at 2025-12-31, from the cover of the [20-F filed 2026-02-26](/filings/0001003935-26-000010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.